Outcome and Minimal Residual Disease Monitoring in t(16;21) Acute Myeloid Leukemia Patients Receiving Allogeneic Hematologic Stem Cell Transplantation

• t(16;21) AML is an indication for allo-HSCT.• The TLS-ERG transcript levels reflected MRD and may predict relapse after HSCT.• The TLS-ERG transcript levels might guide effective intervention.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research